These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Updated American Urological Association Guidelines for the Management of Benign Prostatic Hyperplasia: Prostatic Artery Embolization Made it into the Guidelines! Bilhim T; McWilliams JP; Bagla S Cardiovasc Intervent Radiol; 2024 Jan; 47(1):150-153. PubMed ID: 38010505 [No Abstract] [Full Text] [Related]
6. Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia. Kløw NE; Grøtta OJ; Bay D; Sandbæk G; Johansen TEB; Hagen T; Baco E Acta Radiol; 2019 Sep; 60(9):1175-1180. PubMed ID: 30450921 [No Abstract] [Full Text] [Related]
7. Prostate artery embolization using liquid embolic agents: Is it the future or just a trend? Boeken T Diagn Interv Imaging; 2024 Apr; 105(4):123-124. PubMed ID: 38413272 [No Abstract] [Full Text] [Related]
8. Cone-beam CT findings during prostate artery embolization for benign prostatic hyperplasia-induced lower urinary tract symptoms: a case report. Chen CB; Chou CT; Chen YL BMC Urol; 2017 Dec; 17(1):120. PubMed ID: 29258481 [TBL] [Abstract][Full Text] [Related]
9. Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia in the Setting of Bladder Calculi. Kim JI; Brader R; Viprakasit DP; Isaacson AJ J Vasc Interv Radiol; 2017 Feb; 28(2):306-308. PubMed ID: 28110763 [No Abstract] [Full Text] [Related]
10. Prostate Artery Embolization for Benign Prostatic Hyperplasia: Rationale for the Use of N-Butyl Cyanoacrylate Glue as an Embolic Agent. Loffroy R; Guillen K; Comby PO; Chevallier O Cardiovasc Intervent Radiol; 2022 Jun; 45(6):824-825. PubMed ID: 35441241 [No Abstract] [Full Text] [Related]